Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSealand Cap Regulatory News (SCGL)

  • This share is currently suspended. It was suspended at a price of 0.25

Share Price Information for Sealand Cap (SCGL)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £16.37m
SCGL Live PriceLast checked at - London Stock Exchange

Intraday Sealand Cap Share Chart

Issue of Equity

21 Dec 2022 07:00

RNS Number : 3893K
Sealand Capital Galaxy Limited
21 December 2022
 

For release: 21 December 2022

 

Sealand Capital Galaxy Limited

("Sealand" or the "Company")

 

Issue of Equity

 

Sealand Capital Galaxy Limited (LSE: SCGL) announces that it has agreed to issue 115,211,604 new ordinary shares to its Executive Chairman, Law Chung Lam Nelson, in return for the partial conversion of the loan owed by the Company to him. The conversion price per share is ÂŁ0.0021, being the closing bid price on 15 December 2022, making a total conversion of ÂŁ241,944. The Board of the Company welcomes this transaction as being an important step in strengthening the balance sheet of the Company and preserving the Company's cash. Following this, Mr Law will own 50.7% of the enlarged equity of the Company.

 

Application will be made for the 115,211,604 new ordinary shares to be admitted to trading which is expected to be on or around 5 January 2023.

 

The new ordinary shares will rank pari passu with the existing ordinary shares of the Company. Following the issue of the new ordinary shares, the Company's issued share capital will comprise of 715,815,080 ordinary shares. This figure of 715,815,080 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

 

-Ends-

 

Enquiries:

 

 

Sealand Capital Galaxy Limited 

Law Chung Lam Nelson, Executive Chairman

Geoffrey Griggs, Independent Non-executive Director

 

+ 44 (0) 753 795 9788

+44 (0) 20 7623 3673

 

 

Novum Securities Limited 

David Coffman/ Daniel Harris

+ 44 (0) 20 7399 9400

 

Notes to Editors:

 

The Company's Shares are traded on the Official List of the London Stock Exchange's main market for listed securities under the ticker SCGL.

 

Further information on Sealand is available on its website http://www.scg-ltd.com/ 

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation, requiring notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Law Chung Lam Nelson

 

2

 

Reason for the notification

Grant of Options and Placing and Issue of Shares

a)

 

Position/status

 

 Executive Chairman

 

b)

 

Initial notification /Amendment 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sealand Capital Galaxy Limited

b)

 

LEI

 

2138009EB25MJIULQO19

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of ÂŁ0.0001 each ("Shares")

 

Identification code

ISIN Code:

KYG7948E1026

b)

 

Nature of the transaction

 

Issue of equity

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

0.21p

115,211,604 Shares

 

 

d)

 

Aggregated information

- Aggregated volume

115,211,604 Shares

 

- Price

0.21p

e)

 

Date(s) of the transaction

 

20 December 2022

f)

 

Place of the transaction

 

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOETMBPTMTTTBAT
Date   Source Headline
30th Apr 20267:00 amRNSAssignment of CLN Investment in EVOO AI plc
29th Apr 20267:48 amRNSTemporary Suspension
30th Mar 202611:50 amRNSDirector/PDMR Shareholding
30th Mar 202611:38 amRNSCLN Conversion, Exercise of Warrants & TVR
26th Mar 202611:48 amRNSResult of General Meeting
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
16th Mar 20269:19 amRNSDirector/PDMR Shareholding
11th Mar 202611:10 amRNSIssue of Equity
6th Mar 20264:54 pmRNSNotice of General Meeting
17th Feb 20267:00 amRNSAppointment of Financial Adviser
27th Jan 20264:00 pmRNSStrategic Update and Business Expansion
21st Jan 20264:00 pmRNSDirector Appointment and CFO Appointment
6th Jan 202612:43 pmRNSStatement re Share Price Movement
8th Dec 20253:00 pmRNSDirector Appointment
7th Nov 202512:05 pmRNSPublication of a Prospectus
30th Sep 20251:30 pmRNSHalf-year Report
22nd May 202510:22 amRNSExercise of Warrants
30th Apr 20255:00 pmRNSResults of General Meetings of Warrant Holders
30th Apr 20254:55 pmRNSFinal Results for the Year Ended 31 December 2024
25th Apr 20254:11 pmRNSNotice of General Meetings of Warrant Holders
14th Mar 20257:00 amRNS-REVOO AI PLC Appoints Gordon Radley as New Director
6th Mar 20257:00 amRNS-REVOO’s acceptance into the NVIDIA Connect Program
28th Feb 20254:33 pmRNS-RCEO Interviewed by StockBox Media
28th Feb 20257:00 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSSelection of Strategic Development Partner
24th Feb 20257:00 amRNS-RCorporate Update - Strategic Growth Initiatives
31st Jan 20254:32 pmRNSExercise of Convertible Loan Note and TVR
27th Jan 20257:00 amRNSFormation of ‘SEA-VOO AI ASIA’
20th Jan 20259:17 amRNSAppointment of Chief Executive Officer
10th Jan 20252:50 pmRNSAGM RESULTS AND INVESTMENT IN EVOO AI PLC
6th Jan 20253:24 pmRNSStatement re Share Price Movement
30th Dec 20247:00 amRNSConditional Issue of Equity and Issue of CLN
16th Dec 20247:00 amRNSNotice of AGM
4th Dec 20242:07 pmRNSShare Price Movement
22nd Nov 202410:08 amRNSConditional Investment Agreement
30th Sep 20247:00 amRNSInterim Results
11th Sep 20247:00 amRNSIssue of Equity
30th Apr 202412:30 pmRNSFinal Results
29th Jan 20247:00 amRNSIssue of Equity
29th Sep 20237:00 amRNSUnaudited Interim Results
16th Jun 20237:00 amRNSLifting of suspension, recommencement of trading
6th Jun 202310:11 amRNSREPLACEMENT: MOU WITH PARTNER IN GREATER CHINA
6th Jun 20239:13 amRNSMOU SIGNED WITH PARTNER IN GREATER CHINA
5th Jun 20233:02 pmRNSFinal results for the year ended 31 December 2022
2nd May 20237:57 amRNSDELAY IN PUBLISHING AUDITED FINANCIAL STATEMENTS
17th Apr 20237:00 amRNSHH Simonsen distributorship agreement update
30th Dec 20227:00 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSIssue of Equity
27th Sep 20227:00 amRNSUnaudited Interim Results
30th Jun 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.